Effects of SGLT2 inhibition via empagliflozin on cognitive and physical impairment in frail diabetic elders with chronic kidney disease

Pasquale Mone, Germano Guerra, Angela Lombardi, Maddalena Illario, Antonella Pansini, Anna Marro, Salvatore Frullone, Alessandro Taurino, Daniela Sorriento, Veronica Verri, Guido Iaccarino, Gaetano Santulli

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageEnglish (US)
Article number107055
JournalPharmacological Research
Volume200
DOIs
StatePublished - Feb 2024

Keywords

  • Aging
  • Empagliflozin
  • Immunology
  • Lipid pharmacology
  • SGLT2 inhibitors

ASJC Scopus subject areas

  • Pharmacology

Cite this